Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Sep 26, 2022

Accession no.
0001209191-22-051201
Filed
Sep 26, 2022, 6:59 AM ET
Trade date
Sep 23, 2022
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions. Open-market purchases total $92.3K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 23, 2022Common StockPPurchaseAcquired+31,984$1.84+$58,850.56197,688,678Indirect
Sep 23, 2022Common StockPPurchaseAcquired+835$1.85+$1,540.58197,689,513Indirect
Sep 23, 2022Common StockPPurchaseAcquired+1,300$1.85+$2,405197,690,813Indirect
Sep 23, 2022Common StockPPurchaseAcquired+4,337$1.86+$8,045.14197,695,150Indirect
Sep 23, 2022Common StockPPurchaseAcquired+11,544$1.86+$21,471.84197,706,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)